Evaluate Efficacy and Safety of Saxagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Saxagliptin is a new investigational medication being developed for treatment of type 2
diabetes. This study is designed to evaluate the efficacy and safety in adult patients who
have inadequate glycaemic control when treated with metformin in addition to diet and
exercise.